Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), ...

CLDN18.2-high expression occurred in 48.3% of evaluable advanced cases, exceeding historical estimates and supporting routine standardized immunohistochemistry aligned with zolbetuximab phase III ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

Assessment of Practices, Competence, and Associated Factors among Physicians Background: Breaking bad news is a demanding part of clinical work, and how it is delivered can shape patient trust, ...

4) Pearson correlation analysis was employed to investigate the relationship between spiritual needs, perceived burden, and social support among live cancer patients. If the data conform to a normal ...